Results 81 to 90 of about 3,031 (144)

Safety, tolerability, and pharmacokinetics of faldaprevir after single increasing doses in healthy subjects. [PDF]

Front Pharmacol
Yong CL, Sennewald R, Nehmiz G, Quinson AM, Huang F.   +4 more
europepmc   +1 more source

Accelerating antiviral drug discovery: early hazard detection with a dual zebrafish and cell culture screen of a 403 compound library. [PDF]

Arch Toxicol
Truong L, Bieberich AA, Fatig RO, Rajwa B, Simonich MT, Tanguay RL.   +5 more
europepmc   +1 more source

Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA. [PDF]

J Biol Chem
Suresh S, Shaw AL, Akintola DK, Lunke M, Doerr S, Rohilla P, Balla T, Yip CK, Hansen SD, Cobb JA, Burke JE.   +10 more
europepmc   +1 more source

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes. [PDF]

Sci Rep
Brzdęk M, Zarębska-Michaluk D, Rzymski P, Lorenc B, Janocha-Litwin J, Berak H, Tomasiewicz K, Sitko M, Mazur W, Janczewska E, Dybowska D, Klapaczyński J, Parfieniuk-Kowerda A, Jaroszewicz J, Piekarska A, Flisiak R.   +15 more
europepmc   +1 more source

An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease. [PDF]

Microbiol Spectr
Sigurdardóttir S, Silva SF, Tiukova I, Alalam H, King RD, Grøtli M, Eriksson LA, Sunnerhagen P.   +7 more
europepmc   +1 more source

Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination. [PDF]

Clin Med (Lond)
Farooq HZ, Foster GR.
europepmc   +1 more source

Cyclosporine A sterically inhibits statin transport by solute carrier OATP1B1. [PDF]

J Biol Chem
Sung MW, Hu K, Hurlimann LM, Lees JA, Fennell KF, West MA, Costales C, Rodrigues AD, Zimmermann I, Dawson RJP, Liu S, Han S.   +11 more
europepmc   +1 more source

Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs). [PDF]

J Hepatocell Carcinoma
Salama M, Darwesh N, Elsabaawy MM, Abdelsameea E, Gomaa A, Sabry A.   +5 more
europepmc   +1 more source

Repurposing FDA-Approved Drugs as Potential Inhibitors of Feline Infectious Peritonitis Virus 3CL^pro: An Integrated In Silico and In Vitro Study with Synergistic Combination Analysis. [PDF]

ACS Pharmacol Transl Sci
Lueangaramkul V, Mana N, Thangthamniyom N, Semkum P, Lekcharoensuk P, Limprasutr V, Theerawatanasirikul S.   +6 more
europepmc   +1 more source

Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? [PDF]

J Clin Med
Perrella A, Caturano A, de Sio I, Bellopede P, Maddaloni A, Vitale LM, Rinaldi B, Mormone A, Izzi A, Sbreglia C, Bernardi FF, Trama U, Berretta M, Galiero R, Vetrano E, Sasso FC, Franci G, Marfella R, Rinaldi L.   +18 more
europepmc   +1 more source